肾内科学(第2版)
上QQ阅读APP看书,第一时间看更新

参考文献

1.许国双,吴镝.尿酸与肾脏.西安:第四军医大学出版社,2008:24-217.
2. McQueen FM,Chhana A,Dalbeth N.Mechanisms of joint damage in gout:evidence from cellular and imaging studies.Nat Rev Rheumatol,2012,8(3):173-181.
3. Han SY,Lee NK,Kim KH,et al.Transcriptional induction of cyclooxygenase-2 in osteoclast precursors is involved in RANKL-induced osteoclastogenesis. Blood,2005,106:1240-1245.
4. Zwerina J,Redlich K,Polzer K,et al.TNF-induced structural joint damage is mediated by IL-1.Proc.Natl Acad Sci USA,2007,104:11742-11747.
5. Kim JH,Jin HM,Kim K,et al.The mechanism of osteoclast differentiation induced by IL-1. J Immunol,2009,183:1862-1870.
6. Boyce BF,Xing L.Biology of RANK,RANKL,and osteoprotegerin.Arthritis Res Ther,2007,9(Suppl 1):S1.
7. Horowitz MC,Xi Y,Wilson K,et al.Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev,2001,12(1):9-18.
8. Dalbeth N,Smith T,Nicolson B,et al.Enhanced osteoclastogenesis in patients with tophaceous gout:urate crystals promote osteoclast development through interactions with stromal cells.Arthritis Rheum,2008,58:1854-1865.
9. Denoble AE,Huffman KM,Stabler TV,et al.Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation.Proc Natl Acad Sci USA,2011,108:2088-2093.
10. Sánchez-Lozada LG,Tapia E,Santamaría J,et al.Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int,2005,67:237-247.
11. Mazzali M,Kanellis J,Han L,et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol,2002,282:991-997.
12. Kang DH,Nakagawa T.Uric acid and chronic renal disease:possible implication of hyperuricemia on progression of renal disease.Semin Nephrol,2005,25:43-49.
13. Xu GS,Wu D,Chen XM,et al.Generation of mouse antihuman urate anion exchanger antibody by genetic immunization and its identification. Chin Med J,2005,118:627-632.
14.吴镝,张萍,陈香美,等.人肾尿酸转运蛋白1基因克隆、抗体制备及其在肾小管上皮细胞中的定位.解放军医学杂志,2005,30:397-400.
15. Xu GS,Wu D,Chen XM,et al.Development of high-specificity antibodies against renal urate transporters using genetic immunization.J Biochem Mol Biol,2006,39(6):696-702.
16. Xu GS,Wu D,Chen X,et al.Aldosterone-induced upregulation of urate transporter 1 may be responsible for hyperuricemia.Endocrine,2007,13:145(abstract).
17. Schlesinger N.Diagnosis of gout:clinical,laboratory,and radiologic findings.Am J Manag Care,2005,11(15 Suppl):S443-50.
18. Perez-Ruiz F,Dalbeth N,Urresola A,et al. Imaging of gout:findings and utility. Arthritis Res Ther,2009,11 (3):232.
19. Rettenbacher T,Ennemoser S,Weirich H,et al.Diagnostic imaging of gout:comparison of high-resolution US versus conventional X-ray.Eur Radiol,2008,18:621-630.
20. Paparo F,Zampogna G,Fabbro E,et al.Imaging of tophi with an extremity-dedicated MRI system.Clin Exp Rheumatol,2011,29:519-526.
21. Perez-Ruiz F,Martin I,Canteli B.Ultrasonographic measurement of tophi as an outcome measure for chronic gout. J Rheumatol,2007,34:1888-1893.
22. Ruoff G.The Treatment of Gout.J Family practice,2012,61(6):S11-S15.
23.李宏超,伍沪生.痛风和新型降尿酸药:非布索坦.临床药物治疗杂志,2012,10(1):52-55,62.
24. Garay RP,El-Gewely MR,Labaune JP,et al.Therapeutic perspectives on uricases for gout.Joint Bone Spine,2012,79(3):237-242.
25. Sundy JS.Progress in the pharmacotherapy of gout.Curr Opin Rheumatol,2010,22(2):188-193.
26. Terkeltaub R.Update on gout:new therapeutic strategies and options.Nat Rev Rheumatol,2010,6(1):30-38.
27. Singh JA.Emerging therapies for gout.Expert Opin Emerg Drugs,2012,17(4):511-518.
28. Harrold L.New developments in gout.Curr Opin Rheumatol,2013,25(3):304-309.
29. Crittenden DB,Pillinger MH.New therapies for gout.Annu Rev Med,2013,64:325-337.
30. Schlesinger N.Treatment of chronic gouty arthritis:it is not just about urate-lowering therapy. Semin Arthritis Rheum,2012,42(2):155-165.
31. Curiel RV,Guzman NJ. Challenges associated with the management of gouty arthritis in patients with chronic kidney disease:a systematic review. Semin Arthritis Rheum,2012,42(2):166-178.
32. Johnson RJ,Nakagawa T,Jalal D,et al. Uric acid and chronic kidney disease:which is chasing which?Nephrol Dial Transplant,2013,28(9):2221-2228.
33. Harrold L.New developments in gout.Curr Opin Rheumatol,2013,25(3):304-309.